Shagun Singh
Stock Analyst at RBC Capital
(2.50)
# 2,298
Out of 4,876 analysts
207
Total ratings
47.19%
Success rate
-0.65%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Reiterates: Outperform | $181 | $152.01 | +19.07% | 21 | Jun 5, 2025 | |
| MDT Medtronic | Maintains: Outperform | $105 → $101 | $86.18 | +17.20% | 21 | May 22, 2025 | |
| OM Outset Medical | Maintains: Sector Perform | $14 → $21 | $20.13 | +4.32% | 11 | May 21, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $125 → $112 | $91.74 | +22.08% | 14 | May 6, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $150 → $145 | $119.58 | +21.26% | 20 | May 2, 2025 | |
| ZYXI Zynex | Maintains: Sector Perform | $5 → $4 | $2.61 | +53.26% | 7 | Apr 30, 2025 | |
| PEN Penumbra | Maintains: Outperform | $315 → $330 | $253.58 | +30.14% | 14 | Apr 24, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $116 → $120 | $104.58 | +14.74% | 15 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $630 → $605 | $534.19 | +13.26% | 14 | Apr 23, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $140 → $145 | $133.67 | +8.48% | 13 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $215 | $129.71 | +65.75% | 5 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $340 | $309.83 | +9.74% | 1 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $55 | $19.11 | +187.81% | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $77.15 | +10.17% | 21 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $390.40 | +11.42% | 19 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $92 | $58.82 | +56.41% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $115 | $85.04 | +35.23% | 4 | Oct 25, 2024 |
Johnson & Johnson
Jun 5, 2025
Reiterates: Outperform
Price Target: $181
Current: $152.01
Upside: +19.07%
Medtronic
May 22, 2025
Maintains: Outperform
Price Target: $105 → $101
Current: $86.18
Upside: +17.20%
Outset Medical
May 21, 2025
Maintains: Sector Perform
Price Target: $14 → $21
Current: $20.13
Upside: +4.32%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Outperform
Price Target: $125 → $112
Current: $91.74
Upside: +22.08%
Teleflex
May 2, 2025
Maintains: Sector Perform
Price Target: $150 → $145
Current: $119.58
Upside: +21.26%
Zynex
Apr 30, 2025
Maintains: Sector Perform
Price Target: $5 → $4
Current: $2.61
Upside: +53.26%
Penumbra
Apr 24, 2025
Maintains: Outperform
Price Target: $315 → $330
Current: $253.58
Upside: +30.14%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $116 → $120
Current: $104.58
Upside: +14.74%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $630 → $605
Current: $534.19
Upside: +13.26%
Abbott Laboratories
Apr 17, 2025
Maintains: Outperform
Price Target: $140 → $145
Current: $133.67
Upside: +8.48%
Apr 15, 2025
Maintains: Outperform
Price Target: $260 → $215
Current: $129.71
Upside: +65.75%
Mar 6, 2025
Initiates: Outperform
Price Target: $340
Current: $309.83
Upside: +9.74%
Feb 27, 2025
Maintains: Outperform
Price Target: $65 → $55
Current: $19.11
Upside: +187.81%
Feb 12, 2025
Reiterates: Outperform
Price Target: $85
Current: $77.15
Upside: +10.17%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $390.40
Upside: +11.42%
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $58.82
Upside: +56.41%
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $85.04
Upside: +35.23%